Change in the Binding of [11C]BU99008 to Imidazoline I2 Receptor Using Brain PET in Zucker Rats

被引:4
|
作者
Kawamura, Kazunori [1 ]
Yamasaki, Tomoteru [1 ]
Zhang, Yiding [1 ]
Wakizaka, Hidekatsu [2 ]
Hatori, Akiko [1 ]
Xie, Lin [1 ]
Fujinaga, Masayuki [1 ]
Zhang, Ming-Rong [1 ]
机构
[1] Natl Inst Quantum & Radiol Sci & Technol, Dept Radiopharmaceut Dev, Natl Inst Radiol Sci, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan
[2] Natl Inst Quantum & Radiol Sci & Technol, Dept Med Phys, Natl Inst Radiol Sci, Chiba 2638555, Japan
关键词
C-11]BU99008; Imidazoline receptor; I-2; Positron emission tomography; Obesity; Zucker rats; IN-VIVO EVALUATION; MONOAMINE-OXIDASE; HIGH-AFFINITY; LIGAND; OBESITY; SITES; FOOD; LOCALIZATION; RADIOLIGAND; AGMATINE;
D O I
10.1007/s11307-018-1206-y
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PurposeThe imdazoline I-2 receptor (I2R) has been found in the feeding centers of the brain, such as the hypothalamus, and certain I2R ligands have been reported to stimulate food intake. Thus, it has been proposed that I2R may play a role in feeding control. [C-11]BU99008 was developed as a positron emission tomography (PET) tracer for imaging of I2R. [C-11]BU99008 displayed relatively high brain penetration and specific binding by brain PET studies in preclinical studies. Here, we evaluated a pathological condition caused by obesity related to I2R function by quantitative PET study using [C-11]BU99008.ProceduresPET scans were acquired in the Zucker (ZUC) lean and fatty rats, radioactivity and metabolites of plasma were measured, and the kinetic parameters were estimated.ResultsRadioactivity levels after the injection of [C-11]BU99008 in the hypothalamus of both ZUC lean and fatty rats were highly accumulated, and then gradually decreased until 60min after the injection. The accumulated radioactivity from 30 to 60min after the injection in the hypothalamus of the ZUC fatty rats was 1.3 times greater than that of lean rats. The volume of distribution (V-T) estimated by Logan graphical analysis in the hypothalamus of the ZUC fatty rats was 1.8 times greater than that in the ZUC lean rats. In metabolite analysis, the percentages of the unchanged form in the plasma of the ZUC fatty rats at 60min after the injection (5.0%) was significantly lower than that of lean rats (9.1%).ConclusionsBy PET imaging using [C-11]BU99008, we demonstrated that the accumulated radioactivity and estimated V-T value in the feeding center of ZUC lean rats was lower than that in fatty rats. PET studies using [C-11]BU99008 may contribute to elucidate a pathological condition caused by obesity related to I2R function.
引用
收藏
页码:105 / 112
页数:8
相关论文
共 50 条
  • [1] Change in the Binding of [11C]BU99008 to Imidazoline I2 Receptor Using Brain PET in Zucker Rats
    Kazunori Kawamura
    Tomoteru Yamasaki
    Yiding Zhang
    Hidekatsu Wakizaka
    Akiko Hatori
    Lin Xie
    Masayuki Fujinaga
    Ming-Rong Zhang
    Molecular Imaging and Biology, 2019, 21 : 105 - 112
  • [2] Synthesis and in vivo evaluation of [11C]BU99008 as a ligand for the imidazoline I2 binding site
    Kealey, Steven
    Husbands, Stephen M.
    Casey, Emma
    Salinas, Cristian A.
    Parker, Christine A.
    Jakobsen, Steen
    Tyacke, Robin J.
    Nutt, David J.
    Gee, Antony D.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2011, 54 : S304 - S304
  • [3] Synthesis and in vivo evaluation of [11C]BU99008 as a ligand for the imidazoline 12 binding site
    Kealey, Steven
    Husbands, Stephen
    Casey, Emma M.
    Salinas, Cristian A.
    Parker, Christine A.
    Jakobsen, Steen
    Tyacke, Robin J.
    Nutt, David J.
    Gee, Antony D.
    NEUROIMAGE, 2010, 52 : S127 - S128
  • [4] Evaluation of Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson's disease: an in vivo [11C] BU99008 PET study
    Wilson, H.
    Dervenoulas, G.
    Pagano, G.
    Tyacke, R.
    Myers, J.
    Gunn, R.
    Rabiner, E.
    Nutt, D. J.
    Politis, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 1005 - 1005
  • [5] Evaluation of imidazoline 2 binding sites reflecting astroglia pathology in Huntington's disease: an in vivo [11C] BU99008 PET study
    Wilson, H.
    Niccolini, F.
    Dervenoulas, G.
    Tyacke, R.
    Myers, J.
    Gunn, R.
    Nutt, D. J.
    Rabiner, E.
    Tabrizi, S. J.
    Politis, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 317 - 318
  • [6] Evaluation of Imidazoline 2 binding sites reflecting astroglia pathology in Huntington's Disease: An in vivo [11C]BU99008 PET study
    Wilson, H.
    Niccolini, F.
    Dervenoulas, G.
    Tyacke, R.
    Myers, J.
    Gunn, R.
    Nutt, D.
    Rabiner, E.
    Tabrizi, S.
    Politis, M.
    MOVEMENT DISORDERS, 2019, 34 : S836 - S836
  • [7] Evaluation of Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson's Disease: An in vivo [11C]BU99008 PET study
    Wilson, H.
    Dervenoulas, G.
    Pagano, G.
    Tyacke, R.
    Myers, J.
    Gunn, R.
    Rabiner, E.
    Nutt, D.
    Politis, M.
    MOVEMENT DISORDERS, 2019, 34 : S835 - S836
  • [8] Imaging Imidazoline-I2 Binding Sites in Porcine Brain Using 11C-BU99008
    Kealey, Steven
    Turner, Emma M.
    Husbands, Stephen M.
    Salinas, Cristian A.
    Jakobsen, Steen
    Tyacke, Robin J.
    Nutt, David J.
    Parker, Christine A.
    Gee, Antony D.
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (01) : 139 - 144
  • [9] A useful PET probe [11C]BU99008 with ultra-high specific radioactivity for small animal PET imaging of I2-imidazoline receptors in the hypothalamus
    Kawamura, Kazunori
    Shimoda, Yoko
    Yui, Joji
    Zhang, Yiding
    Yamasaki, Tomoteru
    Wakizaka, Hidekatsu
    Hatori, Akiko
    Xie, Lin
    Kumata, Katsushi
    Fujinaga, Masayuki
    Ogawa, Masanao
    Kurihara, Yusuke
    Nengaki, Nobuki
    Zhang, Ming-Rong
    NUCLEAR MEDICINE AND BIOLOGY, 2017, 45 : 1 - 7
  • [10] Radiosynthesis and evaluation of [11C]BU99008 with ultra-high specific activity as a PET ligand for imaging I2-imidazoline receptors.
    Kawamura, Kazunori
    Shimoda, Yoko
    Yui, Joji
    Fujinaga, Masayuki
    Yamasaki, Tomoteru
    Hatori, Akiko
    Xie, Lin
    Zhang, Yiding
    Kumata, Katsushi
    Ogawa, Masanao
    Kurihara, Yusuke
    Nengaki, Nobuki
    Wakizaka, Hidekatsu
    Zhang, Ming-Rong
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2015, 58 : S290 - S290